Welcome > Support > Âü°íÀÚ·á  
 
 
E
 
±Ûº¸±â
¼º¸í ÆÄ³ªÁø     (Date : 2009-05-29 11:25:21)
Á¦¸ñ [³í¹®] [Globin reduction PNA] À¯ÀüÀÚ ¹ßÇöºÐ¼®À§ÇÑ Ç÷¾×ÀÇ Àü󸮿¡ ÃÖ°í
³»¿ë

À¯ÀüÀÚ ¹ßÇö ºÐ¼®À» À§ÇÑ Ç÷¾× Àü󸮿¡ globin reduction PNA°¡ °¡Àå È¿°úÀûÀ̾ú´Ù´Â ³í¹®ÀÌ ÃÖ±Ù ¹ßÇ¥µÇ¾ú½À´Ï´Ù.

==================================================================================

BMC Genomics 2009, 10:2
doi:10.1186/1471-2164-10-2

Gene expression profiling of whole blood: Comparison of target preparation methods for accurate and reproducible microarray analysis

Kristina Vartanian, Rachel Slottke, Timothy Johnstone, Amanda Casale, Stephen R Planck, Dongseok Choi, Justine R Smith, James T Rosenbaum, Christina A Harrington


Abstract

Background
Peripheral blood is an accessible and informative source of transcriptomal information for many human disease and pharmacogenomic studies. While there can be significant advantages to analyzing RNA isolated from whole blood, particularly in clinical studies, the preparation of samples for microarray analysis is complicated by the need to minimize artifacts associated with highly abundant globin RNA transcripts. The impact of globin RNA transcripts on expression profiling data can potentially be reduced by using RNA preparation and labeling methods that remove or block globin RNA during the microarray assay. We compared four different methods for preparing microarray hybridization targets from human whole blood collected in PAXGene tubes. Three of the methods utilized the Affymetrix one-cycle cDNA synthesis/in vitro transcription protocol but varied treatment of input RNA as follows: i. no treatment; ii. treatment with GLOBINclear; or iii. treatment with globin PNA oligos. In the fourth method cDNA targets were prepared with the Ovation amplification and labeling system.

Results
We find that microarray targets generated with labeling methods that reduce globin mRNA levels or minimize the impact of globin transcripts during hybridization detect more transcripts in the microarray assay compared with the standard Affymetrix method. Comparison of microarray results with quantitative PCR analysis of a panel of genes from the NF-kappa B pathway shows good correlation of transcript measurements produced with all four target preparation methods, although method-specific differences in overall correlation were observed. The impact of freezing blood collected in PAXGene tubes on data reproducibility was also examined. Expression profiles show little or no difference when RNA is extracted from either fresh or frozen blood samples.

Conclusion

RNA preparation and labeling methods designed to reduce the impact of globin mRNA transcripts can significantly improve the sensitivity of the DNA microarray expression profiling assay for whole blood samples. While blockage of globin transcripts during first strand cDNA synthesis with globin PNAs resulted in the best overall performance in this study, we conclude that selection of a protocol for expression profiling studies in blood should depend on several factors, including implementation requirements of the method and study design. RNA isolated from either freshly collected or frozen blood samples stored in PAXGene tubes can be used without altering gene expression profiles.

==================================================================================

´õ ¸¹Àº Á¤º¸¸¦ ¿øÇÏ½Ã¸é ´ÙÀ½ »çÀÌÆ®¸¦ Âü°íÇϽʽÿÀ.
http://www.biomedcentral.com/1471-2164/10/2 
http://www.panagene.com/globin-reduction-pna.php


 

 ¹øÈ£   Á¦¸ñ ÀÛ¼ºÀÚ ÆÄÀÏ Á¶È¸
   29           [³í¹®] [ÆÄ³ªÁø ³í¹®¹ßÇ¥]Highly Sensitive.. ÆÄ³ªÁø 4658
   28           [³í¹®] [ÆÄ³ªÁø PNA »ç¿ë] Membrane-base.. ÆÄ³ªÁø 6377
   27           [³í¹®] [PNA FISH] Rapid detectio.. ÆÄ³ªÁø 1328
   26           [³í¹®] [PNA FISH]Detection of St.. ÆÄ³ªÁø 65535
   25           [³í¹®] Handy and prompt DNA sepa.. ÆÄ³ªÁø 53719
   24           [³í¹®] Frequency of and variable.. ÆÄ³ªÁø 3774
   23           [³í¹®] Prospects for antisense p.. ÆÄ³ªÁø 39712
   22           [³í¹®] Sequence-specific bacteri.. ÆÄ³ªÁø 36958
   21           [³í¹®] Carrier PNA for shRNA del.. ÆÄ³ªÁø 21773
¢º           [³í¹®] [Globin reduction PNA] À¯.. ÆÄ³ªÁø 22057
   19           [³í¹®] [Antiviral research] Inhi.. ÆÄ³ªÁø 13924
   18           [³í¹®] [PNA FISH]Development and.. ÆÄ³ªÁø 4589
   17           [³í¹®] [ÆÄ³ªÁø ³í¹®¹ßÇ¥] A Novel PNA bas.. ÆÄ³ªÁø 8632
   16           [³í¹®] rhinoviruses¿Í enterovirus.. ÆÄ³ªÁø 33910
   15           [³í¹®] PNAÀÇ delivery Çâ»óÀ» À§ÇÑ CPP.. ÆÄ³ªÁø 17022
   14           [³í¹®] ÀûÁ¶ ¿øÀÎ Á¶·ùÀÇ µ¿Á¤: PNA FISH ÀÌ.. ÆÄ³ªÁø 33491
   13           [³í¹®] Èí¿¬ÀÚÀÇ Æó¾Ï ¹ßº´ À§Çè ÆÄ³ªÁø 1238
   12           [³í¹®] PNA °ü·Ã ³í¹® (2001~2007. Nov.. ÆÄ³ªÁø 1272
   11           [³í¹®] PNA °ü·Ã ³í¹® (2008³â) ÆÄ³ªÁø 1195
   10           [³í¹®] PNA ÇÕ¼º ¹æ¹ý ÆÄ³ªÁø 1439
 

< 1 2 3 >